Summary:
Stocks to watch on November 3 include ITC, NALCO, KEC International, Trident, Marico, Lupin and NBCC. Investors will track Q2 FY27 earnings, Lupin's USFDA approval, corporate collaborations, subsidiary share allotments and new infrastructure project announcements.
Which Stocks Are in Focus on November 3?
Several companies are likely to remain in focus during Tuesday's trading session, November 3, following their Q2 FY27 financial results and key corporate announcements. ITC, NALCO, KEC International, Trident, Marico, Akums Drugs and Pharmaceuticals, Granules India and PTC India have reported their quarterly results. Lupin, Samvardhana Motherson International, TVS Holdings and NBCC (India) have also announced developments that investors may track.
| Company | Key development |
| ITC | Consolidated net profit declined 18.5% YoY to ₹4,229.3 crore. |
| NALCO | Consolidated net profit increased 28.3% YoY to ₹1,835 crore. |
| KEC International | Consolidated net profit declined 81.5% YoY to ₹29.7 crore. |
| GSFC | Consolidated net profit declined 38.2% YoY to ₹200.2 crore. |
| Trident | Net profit increased 93.1%; board approved a ₹4,650 crore expansion project. |
| Marico | Consolidated net profit increased 29.2% to ₹558 crore. |
| Akums Drugs | Consolidated net profit increased 176.7% to ₹112.9 crore. |
| Granules India | Consolidated net profit increased 39.2% to ₹181.8 crore. |
| PTC India | Consolidated net profit declined 24.8% to ₹143.7 crore. |
| Lupin | Received USFDA approval for Amifampridine Tablets, 10 mg. |
| Samvardhana Motherson | Collaborated with NTU Singapore on Spinheat technology. |
| TVS Holdings | Received an additional 12.55 crore shares in Home Credit India Finance. |
| NBCC | Signed a Bihar redevelopment MoU and secured PMC contracts worth ₹70.50 crore. |
Indian stock markets will remain focused on several companies on Tuesday, November 3, as investors react to September-quarter earnings and key corporate announcements. ITC, National Aluminium Company (NALCO), KEC International, Gujarat State Fertilizers & Chemicals, Trident, Marico, Akums Drugs and Pharmaceuticals, Granules India and PTC India have announced their Q2FY27 results.
Among the major earnings highlights, Akums Drugs and Pharmaceuticals reported a 176.7% year-on-year (YoY) increase in consolidated net profit, while Trident posted 93.1% profit growth. On the other hand, KEC International reported an 81.5% decline in net profit. Apart from earnings, Lupin, Samvardhana Motherson International, TVS Holdings and NBCC (India) are also likely to remain in focus following significant corporate developments.
Alongside company-specific earnings and corporate announcements, investors will also monitor the broader market trend during Tuesday's trading session. The Nifty 50 gained 387.70 points to close at 23,440.80 on November 2, moving above its earlier resistance level of 23,076.90. Read our Nifty prediction for November 3 for the latest technical outlook, including key support and resistance levels, EMA positioning and RSI indicators.
ITC, NALCO and KEC International Announce Q2 FY27 Results
ITC Ltd reported an 18.5% YoY decline in consolidated net profit to ₹4,229.3 crore in Q2FY27, compared with ₹5,186.6 crore in the corresponding quarter last year. However, revenue surged 43.85% to ₹30,578.4 crore from ₹21,255.9 crore.
National Aluminium Company (NALCO) reported a strong quarterly performance, with consolidated net profit increasing 28.3% YoY to ₹1,835 crore from ₹1,429.9 crore. Revenue grew 26.3% to ₹5,419.4 crore from ₹4,292.3 crore.
KEC International reported a significant decline in profitability. Its consolidated net profit plunged 81.5% YoY to ₹29.7 crore from ₹160.8 crore, while revenue declined 10.2% to ₹5,467.7 crore from ₹6,091.6 crore.
Gujarat State Fertilizers & Chemicals (GSFC) reported a 38.2% decline in consolidated net profit to ₹200.2 crore from ₹324.1 crore. However, revenue increased 48.7% to ₹4,740.9 crore from ₹3,187.4 crore.
Trident, Marico and Akums Drugs Report Q2 Earnings
Trident reported a 93.1% YoY increase in consolidated net profit to ₹175.6 crore from ₹90.9 crore. However, revenue declined 3.8% to ₹1,719.5 crore from ₹1,787.2 crore. Additionally, the company's board approved a capacity expansion and modernisation project worth ₹4,650 crore.
Marico reported a 29.2% increase in consolidated net profit to ₹558 crore from ₹432 crore in the corresponding quarter last year. Revenue increased 13% to ₹3,897 crore from ₹3,450 crore.
Akums Drugs and Pharmaceuticals delivered strong quarterly growth, with consolidated net profit surging 176.7% YoY to ₹112.9 crore from ₹40.8 crore. Revenue increased 31.9% to ₹1,342.4 crore from ₹1,017.5 crore.
Granules India reported a 39.2% increase in consolidated net profit to ₹181.8 crore from ₹130.6 crore. Revenue grew 20.3% to ₹1,560 crore from ₹1,297 crore.
PTC India reported a 24.8% decline in consolidated net profit to ₹143.7 crore from ₹191.2 crore. However, revenue increased 6.5% to ₹5,812.1 crore from ₹5,458.7 crore.
Which Stocks Are in Focus Following Corporate Announcements?
Lupin Receives USFDA Approval for Amifampridine Tablets
Lupin received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Amifampridine Tablets, 10 mg. The tablets are bioequivalent to the reference listed drug (RLD), Firdapse Tablets, marketed by Catalyst Pharmaceuticals, Inc. Lupin is among the first ANDA applicants and is eligible for 180 days of shared generic exclusivity.
Samvardhana Motherson Collaborates with NTU Singapore
Samvardhana Motherson International announced a collaboration with Nanyang Technological University (NTU), Singapore, to advance Spinheat, a magnetic induction technology designed to cure industrial coatings within minutes while consuming significantly less energy than conventional oven-based methods.
The collaboration aims to industrialise the technology for real-world applications, including curing resin coatings on automotive and aerospace components.
TVS Holdings Receives Additional Shares in Home Credit India Finance
TVS Holdings has been allotted an additional 12.55 crore equity shares worth ₹483.91 crore in its non-banking financial services subsidiary, Home Credit India Finance (HCIFPL), through a rights issue. Following the additional allotment, its shareholding in HCIFPL remains unchanged at 74.45%.
NBCC Signs Bihar Redevelopment MoU, Secures New Contracts
NBCC (India) signed a Memorandum of Understanding (MoU) with various departments of the Government of Bihar to undertake four redevelopment projects in Patna under Phase I. The projects will be executed on a self-financing basis without any budgetary assistance from the state government.
The expected sale or lease proceeds from the projects are estimated at ₹5,152 crore, while the tentative project cost is pegged at ₹2,000 crore. The project management consultancy (PMC) charges will be 6%, while the marketing fee will be 1.25%.
Additionally, NBCC secured project management consultancy contracts worth ₹70.50 crore from Oil India and Hindustan Aeronautics.
These earnings announcements and corporate developments are likely to keep the 13 stocks in focus during Tuesday's trading session as investors assess quarterly profitability, revenue growth, expansion plans and new business opportunities.
What Should Investors Track on November 3?
The stocks in focus on November 3 reflect a mix of quarterly earnings and company-specific developments. While Akums Drugs, Trident, NALCO and Marico reported growth in consolidated net profit, ITC, KEC International, GSFC and PTC India reported declines. Lupin's USFDA approval, Trident's capacity expansion, Samvardhana Motherson's technology collaboration and NBCC's redevelopment projects are among the other developments investors may monitor during the trading session.
Disclaimer: The article is for informational purposes only and not investment advice.
